MENU

Fox Chase Cancer Center News

January 22, 2020

Robotic Bronchoscopy Found to be Safe, Reliable for Diagnosing Lung Cancer

PHILADELPHIA (January 22, 2020) – In the first published study since the market release of robot-assisted bronchoscopy, researchers at Fox Chase Cancer Center have found the technology to be safe, feasible, and reliable for achieving diagnoses for lung cancer.

January 20, 2020

Fox Chase Cancer Center Welcomes Claudia J. Kasales

PHILADELPHIA (January 20, 2020) – Claudia J. Kasales, MD, MHA, FACR, who will be joining the Department of Diagnostic Imaging as a professor on the academic clinician track. She will begin work at Fox Chase on February 1, 2020.

“Most cysts won’t turn into cancer. However, because of the risk, many patients may consider surgery. It’s a big operation and we want to make sure that only those patients at the greatest cancer risk get surgery,” Weinberg said.
January 16, 2020

Multicenter Pancreatic Cyst Trial Headed by Fox Chase Researcher Launches

PHILADELPHIA (January 16, 2020)—An eight-year multicenter trial to study how often and how fast pancreatic cysts progress to cancer is launching today. Fox Chase Cancer Center serves as the headquarters for the project, although the trial is open to participation at hundreds of sites around the country.

The American Lung Association’s Lung Cancer Discovery Award, a $100,000 grant to research epigenetic factors affecting lung cancer.
January 14, 2020

Johnathan R. Whetstine Awarded Lung Cancer Discovery Award

PHILADELPHIA (January 14, 2020) – Johnathan R. Whetstine, PhD, a program leader for the Cancer Epigenetics Program at Fox Chase Cancer Center, was awarded the American Lung Association’s Lung Cancer Discovery Award, a $100,000 grant to research epigenetic factors affecting lung cancer.

Patients who had enucleoresection as compared to both enucleation and resection had greater risk for positive surgical margins.
January 10, 2020

Surgical Technique for Renal Mass Removal Affected Complications, Outcomes

PHILADELPHIA (January 10, 2020) – Patients who had enucleoresection as compared to both enucleation and resection had greater risk for positive surgical margins.

Jeffrey Farma is a surgical oncologist specializing in colorectal cancer, sarcomas, gastrointestinal stromal tumors, and skin cancer.
January 7, 2020

Farma Elected to Board of Trustees of PA Medical Society

PHILADELPHIA (January 7, 2020) – Jeffrey Farma, MD, FACS, chief of the Division of General Surgery at Fox Chase Cancer Center, was elected to the Board of Trustees by the House of Delegates of the Pennsylvania Medical Society. One of 14 trustees to be elected, Farma was selected to serve as Surgical Specialty Trustee for a term of four years.

“When people use the term ‘local recurrence,’ everyone uses it differently,” Uzzo said. “We developed a framework for people to define what local recurrence means, and then we looked to see whether local recurrence is associated with better or worse survival.”
January 7, 2020

New Classification System Could Better Define Local Recurrence of Kidney Cancers

PHILADELPHIA (January 7, 2020) – Using data from the largest national adjuvant clinical trial in kidney cancer conducted to date, researchers at Fox Chase Cancer Center have developed a novel classification system for local recurrence after surgery for renal cell carcinoma.

January 6, 2020

Pilot Project Competition Awards Announced

PHILADELPHIA (January 6, 2020) – Fox Chase Cancer Center has announced the results of this year’s Pilot Project competition, which is supported in large part by the generosity of donors attending the center’s signature fundraising event, In Vino Vita.

Pages

Connect with Fox Chase